$KE

Earnings To Watch: Kimball Solutions (KE) Reports Q2 Results Tomorrow

Kimball Solutions (KE) is scheduled to report Q2 earnings Wednesday afternoon. The company previously reported revenue of $352.9M, down 5.8% YoY, with EPS in line. For the upcoming quarter, analysts expect revenue to decline 1.9% YoY. The article cites an average analyst price target of $34.25 versus a $25.13 share price.

Original reporting
Published Aug 11, 2026, 3:01 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 3:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Earnings To Watch: Kimball Solutions (KE) Reports Q2 Results Tomorrow — source image
Decision brief

The 30-second read

$KENeutralMed
01

Why it matters

Traders can use the stated consensus (revenue expected to decline 1.9% YoY) and the note that KE has missed revenue estimates multiple times to gauge downside risk if results do not improve.

02

Market read

This is a pre-earnings setup for KE with consensus and peer read-through, implying potential volatility around the release.

03

What to watch

The preview does not include guidance, margin, backlog, or order trends; those details could dominate the reaction more than the revenue YoY headline.

Relevance 5/10Novelty 4/10Timing: ahead of Wednesday afternoon Q2 earnings release

Background

The piece frames Kimball Solutions’ upcoming Q2 earnings, referencing last quarter’s revenue miss and current consensus expectations.

Company-level read

Ticker impact

$KENeutralMedium confidence
Context

Kimball Solutions (KE) is scheduled to report Q2 results Wednesday afternoon, with revenue expectations and recent misses highlighted.

Expected impact

Likely elevated volatility into the print; direction depends on whether revenue decline and any EPS commentary beat or worsen expectations.

Evidence & confidence

The article provides consensus expectations (revenue -1.9% YoY) and notes multiple prior revenue misses, but it does not disclose any new company-specific development beyond the upcoming earnings timing.

Market effects

Electrical systems peers’ recent beats (Atkore, Allegion) may set a higher bar for segment read-through, affecting expectations for KE.

No specific regional impact described.

No global macro or cross-border catalyst described.

Counterpoint

Even with prior revenue misses, the segment has shown strength and investors may be positioned for a rebound, making a modest beat more impactful than usual.

Key entities

  • Kimball Solutions

    Subject of the earnings preview, scheduled to report Q2 results Wednesday afternoon.

  • Atkore

    Peer cited as having reported Q2 revenue growth and a post-results stock jump.

  • Allegion

    Peer cited as having reported Q2 revenue growth and a post-results stock gain.

Related articles

$KEHighAI 9/10

Kimball Electronics, Inc. (KE): Results of Operations and Financial Condition

Kimball Electronics, Inc. (KE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit9918k6302026q410k.htm KIMBALL ELECTRONICS, INC. EX-99.1 Document Exhibit 99.1 KIMBALL ELECTRONICS REPORTS Q4 RESULTS; COMPANY PROVIDES GUIDANCE FOR FISCAL 2027 HIGHLIGHTED BY ORGANIC SALES GROWTH AND ACCRETIVE IMPACT OF THE HELVOET ACQUISITION JASPER, Ind., Augus

$KEMedAI 8/10

Kimball Electronics (Nasdaq: KE) said it acquired Helvoet Polymer Technologies B.V., a Europe/India medical CDMO

Kimball Electronics (Nasdaq: KE) said it acquired Helvoet Polymer Technologies B.V., a Europe/India medical CDMO for microfluidics, diagnostics, and drug delivery, for €90m (~$103m) excluding adjustments. The deal is ~9x Helvoet 2026E adjusted EBITDA, expected accretive to fiscal 2027 adjusted earnings and to grow Kimball’s medical sales in the low double digits. Helvoet 2025 revenue was ~$56m.

$KEMedAI 8/10

Kimball Electronics, Inc.: Kimball Electronics Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.

Kimball Electronics (Nasdaq: KE) said it acquired Europe-based medical CDMO Helvoet Polymer Technologies B.V. for €90m (~$103m, excluding adjustments), about 9x estimated calendar 2026 adjusted EBITDA. The deal adds Europe and India capacity, is expected to be accretive to fiscal 2027 adjusted earnings, and should grow Kimball’s medical sales in the low double digits.

$VRTMed

Vertiv, Atkore, and Kimball Electronics Shares Are Falling, What You Need To Know

Shares of Vertiv, Atkore, and Kimball Electronics fell after the May jobs report pushed the 30-year Treasury yield above 5%, raising financing costs for grid, data center power, and industrial electrification projects. The report said AI data center orders stayed strong, but higher long-term rates could lengthen order cycles. Vertiv fell 4.9%, Atkore 3.8%, and Kimball Electronics 5.1% (to $24.92).